Ocugen (OCGN) Total Non-Current Liabilities (2014 - 2026)

Ocugen's (OCGN) quarterly Total Non-Current Liabilities came in at $30.4 million in Q1 2026, down 4.01% YoY from $31.7 million in Q1 2025, and down 6.88% on a QoQ basis from $32.6 million in Q4 2025.

Ocugen (OCGN) Total Non-Current Liabilities (2014 - 2026) Analysis & Trends

Ocugen (OCGN) has 13 years of Total Non-Current Liabilities data on file, last reported at $30.4 million in Q1 2026.

  • Quarterly Total Non-Current Liabilities fell 4.01% year-over-year to $30.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30.4 million (down 4.01% YoY) and the FY2025 annual result came in at $32.6 million, up 4.54% from the prior year.
  • Total Non-Current Liabilities eased to $30.4 million in Q1 2026, from $32.6 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $33.7 million in Q3 2025 to a low of $2.9 million in Q1 2022.
  • A 5-year average of $14.8 million and a median of $6.0 million in 2022 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2023 — Total Non-Current Liabilities dropped 14.48% — and 2025, when it jumped 507.9%.
  • Tracing OCGN's Total Non-Current Liabilities over 5 years: stood at $6.1 million in 2022, then increased by 12.65% to $6.9 million in 2023, then surged by 352.89% to $31.2 million in 2024, then rose by 4.54% to $32.6 million in 2025, then retreated by 6.88% to $30.4 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $30.4 million (Q1 2026), $32.6 million (Q4 2025), and $33.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 5.92 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 7.74 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 40.00 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 1.53 Bn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.88 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 9.32 Bn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 4.20 Bn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 1.17 Bn
10 Ocugen 457.71 Mn 357.61 Mn - 7.68 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 7.68 Mn
Mar 31, 2026 30.39 Mn
Dec 31, 2025 32.64 Mn
Sep 30, 2025 33.70 Mn
Jun 30, 2025 32.55 Mn
Mar 31, 2025 31.66 Mn
Dec 31, 2024 31.22 Mn
Sep 30, 2024 5.54 Mn
Jun 30, 2024 5.64 Mn
Mar 31, 2024 5.48 Mn
Dec 31, 2023 6.89 Mn
Sep 30, 2023 5.16 Mn
Jun 30, 2023 5.24 Mn
Mar 31, 2023 4.82 Mn
Dec 31, 2022 6.12 Mn
Sep 30, 2022 6.03 Mn
Jun 30, 2022 5.64 Mn
Mar 31, 2022 2.91 Mn
Dec 31, 2021 2.94 Mn
Sep 30, 2021 2.97 Mn